![O41 O41](https://data.pdbj.org/pdbjplus/data/cc/svg/O41.svg) | O41 | Name: | 5-cyclopropyl-N-[1-(methylsulfonyl)piperidin-4-yl]-1,2-oxazole-3-carboxamide | Formula: | C13 H19 N3 O4 S | SMILES: | C1N(CCC(C1)NC(=O)c3cc(C2CC2)on3)S(C)(=O)=O | InChi: | InChI=1S/C13H19N3O4S/c1-21(18,19)16-6-4-10(5-7-16)14-13(17)11-8-12(20-15-11)9-2-3-9/h8-10H,2-7H2,1H3,(H,14,17) | Definition date: | 2019-06-07 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 5-cyclopropyl-N-[1-(methylsulfonyl)piperidin-4-yl]-1,2-oxazole-3-carboxamide |
|
![O6A O6A](https://data.pdbj.org/pdbjplus/data/cc/svg/O6A.svg) | O6A | Name: | N-(1-{[4-(aminomethyl)phenyl]sulfonyl}piperidin-4-yl)-5-cyclopropyl-1,2-oxazole-3-carboxamide | Formula: | C19 H24 N4 O4 S | SMILES: | C2(CCN(S(c1ccc(CN)cc1)(=O)=O)CC2)NC(=O)c3cc(on3)C4CC4 | InChi: | InChI=1S/C19H24N4O4S/c20-12-13-1-5-16(6-2-13)28(25,26)23-9-7-15(8-10-23)21-19(24)17-11-18(27-22-17)14-3-4-14/h1-2,5-6,11,14-15H,3-4,7-10,12,20H2,(H,21,24) | Definition date: | 2019-06-12 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | N-(1-{[4-(aminomethyl)phenyl]sulfonyl}piperidin-4-yl)-5-cyclopropyl-1,2-oxazole-3-carboxamide |
|
![NRE NRE](https://data.pdbj.org/pdbjplus/data/cc/svg/NRE.svg) | NRE | Name: | [(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]methyl]-5-methyl-piperidin-1-yl]-(3-fluoranyl-2-methoxy-phenyl)methanone | Formula: | C20 H23 Br F N3 O2 | SMILES: | COc1c(F)cccc1C(=O)N2C[CH](C)CC[CH]2CNc3ccc(Br)cn3 | InChi: | InChI=1S/C20H23BrFN3O2/c1-13-6-8-15(11-24-18-9-7-14(21)10-23-18)25(12-13)20(26)16-4-3-5-17(22)19(16)27-2/h3-5,7,9-10,13,15H,6,8,11-12H2,1-2H3,(H,23,24)/t13-,15-/m0/s1 | Definition date: | 2019-12-11 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | [(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]methyl]-5-methyl-piperidin-1-yl]-(3-fluoranyl-2-methoxy-phenyl)methanone |
|
![NRK NRK](https://data.pdbj.org/pdbjplus/data/cc/svg/NRK.svg) | NRK | Name: | (1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-~{N}-(5-fluoranylpyridin-2-yl)-2-(3-fluorophenyl)cyclopropane-1-carboxamide | Formula: | C22 H20 F2 N4 O2 | SMILES: | Cc1ncc(OC[C]2(C[CH]2C(=O)Nc3ccc(F)cn3)c4cccc(F)c4)c(C)n1 | InChi: | InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1 | Definition date: | 2019-12-11 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | (1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-~{N}-(5-fluoranylpyridin-2-yl)-2-(3-fluorophenyl)cyclopropane-1-carboxamide |
|
![NXE NXE](https://data.pdbj.org/pdbjplus/data/cc/svg/NXE.svg) | NXE | Name: | ~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide | Formula: | C6 H5 F3 N2 O2 | SMILES: | CC(=O)Nc1onc(c1)C(F)(F)F | InChi: | InChI=1S/C6H5F3N2O2/c1-3(12)10-5-2-4(11-13-5)6(7,8)9/h2H,1H3,(H,10,12) | Definition date: | 2020-01-02 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | ~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide |
|
![NXH NXH](https://data.pdbj.org/pdbjplus/data/cc/svg/NXH.svg) | NXH | Name: | 1-propan-2-yl-3-pyridin-4-yl-urea | Formula: | C9 H13 N3 O | SMILES: | CC(C)NC(=O)Nc1ccncc1 | InChi: | InChI=1S/C9H13N3O/c1-7(2)11-9(13)12-8-3-5-10-6-4-8/h3-7H,1-2H3,(H2,10,11,12,13) | Definition date: | 2020-01-02 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 1-propan-2-yl-3-pyridin-4-yl-urea |
|
![O1S O1S](https://data.pdbj.org/pdbjplus/data/cc/svg/O1S.svg) | O1S | Name: | 6-(5-methyl-1H-pyrazol-4-yl)-2-[(pyrrolidin-1-yl)methyl]thieno[3,2-d]pyrimidin-4(3H)-one | Formula: | C15 H17 N5 O S | SMILES: | n1c(c(cn1)c2sc4c(c2)N=C(CN3CCCC3)NC4=O)C | InChi: | InChI=1S/C15H17N5OS/c1-9-10(7-16-19-9)12-6-11-14(22-12)15(21)18-13(17-11)8-20-4-2-3-5-20/h6-7H,2-5,8H2,1H3,(H,16,19)(H,17,18,21) | Definition date: | 2019-06-04 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 6-(5-methyl-1H-pyrazol-4-yl)-2-[(pyrrolidin-1-yl)methyl]thieno[3,2-d]pyrimidin-4(3H)-one |
|
![O1V O1V](https://data.pdbj.org/pdbjplus/data/cc/svg/O1V.svg) | O1V | Name: | 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one | Formula: | C17 H19 N5 O S | SMILES: | n1c(c(cn1)c2sc3c(c2)N=C(NC3=O)C5CC4CCN5CC4)C | InChi: | InChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m0/s1 | Definition date: | 2019-06-04 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one |
|
![HS4 HS4](https://data.pdbj.org/pdbjplus/data/cc/svg/HS4.svg) | HS4 | Name: | N-oxidanyl-2-[(4-phenylphenyl)sulfonylamino]ethanamide | Formula: | C14 H14 N2 O4 S | SMILES: | O=NC(=O)CNS(=O)(=O)c2ccc(c1ccccc1)cc2 | InChi: | InChI=1S/C14H14N2O4S/c17-14(16-18)10-15-21(19,20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15,18H,10H2,(H,16,17) | Definition date: | 2008-11-04 | Last modified: | 2020-01-07 | Identifier: | N~2~-(biphenyl-4-ylsulfonyl)-N-oxoglycinamide |
|
![FXH FXH](https://data.pdbj.org/pdbjplus/data/cc/svg/FXH.svg) | FXH | Name: | 1-[(dimethylamino)methyl]naphthalen-2-ol | Formula: | C13 H15 N O | SMILES: | CN(C)Cc1c(O)ccc2ccccc12 | InChi: | InChI=1S/C13H15NO/c1-14(2)9-12-11-6-4-3-5-10(11)7-8-13(12)15/h3-8,15H,9H2,1-2H3 | Definition date: | 2018-08-13 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 1-[(dimethylamino)methyl]naphthalen-2-ol |
|
![KJH KJH](https://data.pdbj.org/pdbjplus/data/cc/svg/KJH.svg) | KJH | Name: | 1-methylidenenaphthalen-2-one | Formula: | C11 H8 O | SMILES: | C=C1C(=O)C=Cc2ccccc12 | InChi: | InChI=1S/C11H8O/c1-8-10-5-3-2-4-9(10)6-7-11(8)12/h2-7H,1H2 | Definition date: | 2019-05-24 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 1-methylidenenaphthalen-2-one |
|
![N2V N2V](https://data.pdbj.org/pdbjplus/data/cc/svg/N2V.svg) | N2V | Name: | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine | Formula: | C50 H47 Cl2 N3 O6 | SMILES: | c2(ccc(OCc1cc(Cl)c(cc1)Cl)cc2)C7Oc6cc5CN(C(C(=O)NC(C(=O)O)Cc4ccc(c3c(c(C)ncc3)C)cc4)Cc5cc6OC7)C(c8ccccc8)CC | InChi: | InChI=1S/C50H47Cl2N3O6/c1-4-44(35-8-6-5-7-9-35)55-27-38-26-47-46(60-29-48(61-47)36-15-17-39(18-16-36)59-28-33-12-19-41(51)42(52)22-33)25-37(38)24-45(55)49(56)54-43(50(57)58)23-32-10-13-34(14-11-32)40-20-21-53-31(3)30(40)2/h5-22,25-26,43-45,48H,4,23-24,27-29H2,1-3H3,(H,54,56)(H,57,58)/t43-,44-,45-,48+/m0/s1 | Definition date: | 2019-05-01 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine |
|
![JT0 JT0](https://data.pdbj.org/pdbjplus/data/cc/svg/JT0.svg) | JT0 | Name: | 2-chloro-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-N-(3-methoxypropyl)acetamide | Formula: | C16 H19 Cl N2 O3 S | SMILES: | C(=O)(CCl)N(CCCOC)c2scc(c1ccc(cc1)OC)n2 | InChi: | InChI=1S/C16H19ClN2O3S/c1-21-9-3-8-19(15(20)10-17)16-18-14(11-23-16)12-4-6-13(22-2)7-5-12/h4-7,11H,3,8-10H2,1-2H3 | Definition date: | 2019-07-10 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 2-chloro-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-N-(3-methoxypropyl)acetamide |
|
![LMY LMY](https://data.pdbj.org/pdbjplus/data/cc/svg/LMY.svg) | LMY | Name: | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide | Formula: | C32 H35 F3 N8 O S | SMILES: | CNc1nc(NC2CCN(CC2)Cc3ccc4n(CC56CC(C5)(C6)NC=O)c(cc4c3C)C#N)c7cc(CC(F)(F)F)sc7n1 | InChi: | InChI=1S/C32H35F3N8OS/c1-19-20(3-4-26-24(19)9-22(12-36)43(26)17-30-14-31(15-30,16-30)38-18-44)13-42-7-5-21(6-8-42)39-27-25-10-23(11-32(33,34)35)45-28(25)41-29(37-2)40-27/h3-4,9-10,18,21H,5-8,11,13-17H2,1-2H3,(H,38,44)(H2,37,39,40,41)/t30-,31+ | Definition date: | 2019-03-04 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide |
|
![SFH SFH](https://data.pdbj.org/pdbjplus/data/cc/svg/SFH.svg) | SFH | Name: | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine | Formula: | C16 H17 N7 O7 S | SMILES: | C3(n1c2c(nc1)c(N)ncn2)OC(C(C3O)O)COS(NC(c4cnccc4)=O)(=O)=O | InChi: | InChI=1S/C16H17N7O7S/c17-13-10-14(20-6-19-13)23(7-21-10)16-12(25)11(24)9(30-16)5-29-31(27,28)22-15(26)8-2-1-3-18-4-8/h1-4,6-7,9,11-12,16,24-25H,5H2,(H,22,26)(H2,17,19,20)/t9-,11-,12-,16-/m1/s1 | Definition date: | 2019-10-09 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine |
|
![EGE EGE](https://data.pdbj.org/pdbjplus/data/cc/svg/EGE.svg) | EGE | Name: | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid | Formula: | C18 H15 N5 O5 S | SMILES: | Nc1cc(O)c(cc1N=Nc2ccc(cc2)[S](=O)(=O)Nc3ccccn3)C(O)=O | InChi: | InChI=1S/C18H15N5O5S/c19-14-10-16(24)13(18(25)26)9-15(14)22-21-11-4-6-12(7-5-11)29(27,28)23-17-3-1-2-8-20-17/h1-10,24H,19H2,(H,20,23)(H,25,26)/b22-21+ | Definition date: | 2018-03-18 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid |
|
![EGH EGH](https://data.pdbj.org/pdbjplus/data/cc/svg/EGH.svg) | EGH | Name: | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one | Formula: | C18 H17 Br F N O4 | SMILES: | COc1cc2NC(=O)C[CH](c3cc(Br)ccc3F)c2c(OC)c1OC | InChi: | InChI=1S/C18H17BrFNO4/c1-23-14-8-13-16(18(25-3)17(14)24-2)11(7-15(22)21-13)10-6-9(19)4-5-12(10)20/h4-6,8,11H,7H2,1-3H3,(H,21,22)/t11-/m0/s1 | Definition date: | 2018-03-18 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one |
|
![EGN EGN](https://data.pdbj.org/pdbjplus/data/cc/svg/EGN.svg) | EGN | Name: | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one | Formula: | C23 H32 N3 O2 S | SMILES: | CCN1C(=O)C=C(SCC(=O)N2CC[NH+](CC2)C3CCCCC3)c4ccccc14 | InChi: | InChI=1S/C23H31N3O2S/c1-2-26-20-11-7-6-10-19(20)21(16-22(26)27)29-17-23(28)25-14-12-24(13-15-25)18-8-4-3-5-9-18/h6-7,10-11,16,18H,2-5,8-9,12-15,17H2,1H3/p+1 | Definition date: | 2018-03-19 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one |
|
![L7Y L7Y](https://data.pdbj.org/pdbjplus/data/cc/svg/L7Y.svg) | L7Y | Name: | 5-(4-chlorophenyl)-3-({[3-(morpholine-4-carbonyl)phenyl]amino}methyl)pyridin-2(1H)-one | Formula: | C23 H22 Cl N3 O3 | SMILES: | Clc1ccc(cc1)C2=CNC(=O)C(=C2)CNc3cccc(c3)C(N4CCOCC4)=O | InChi: | InChI=1S/C23H22ClN3O3/c24-20-6-4-16(5-7-20)18-12-19(22(28)26-14-18)15-25-21-3-1-2-17(13-21)23(29)27-8-10-30-11-9-27/h1-7,12-14,25H,8-11,15H2,(H,26,28) | Definition date: | 2019-02-11 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 5-(4-chlorophenyl)-3-({[3-(morpholine-4-carbonyl)phenyl]amino}methyl)pyridin-2(1H)-one |
|
![QKD QKD](https://data.pdbj.org/pdbjplus/data/cc/svg/QKD.svg) | QKD | Name: | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | Formula: | C12 H17 N O2 S2 | SMILES: | C2N(C(OCC)=O)CCC(c1sccc1)SC2 | InChi: | InChI=1S/C12H17NO2S2/c1-2-15-12(14)13-6-5-11(17-9-7-13)10-4-3-8-16-10/h3-4,8,11H,2,5-7,9H2,1H3/t11-/m0/s1 | Definition date: | 2019-11-06 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
![KHQ KHQ](https://data.pdbj.org/pdbjplus/data/cc/svg/KHQ.svg) | KHQ | Name: | 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one | Formula: | C28 H31 F3 N8 O | SMILES: | C[CH](N1CCN(CC1)C(=O)CC(F)(F)F)c2ccnc(Nc3[nH]c4ccc(cc4n3)c5cnn(CC6CC6)c5)c2 | InChi: | InChI=1S/C28H31F3N8O/c1-18(37-8-10-38(11-9-37)26(40)14-28(29,30)31)20-6-7-32-25(13-20)36-27-34-23-5-4-21(12-24(23)35-27)22-15-33-39(17-22)16-19-2-3-19/h4-7,12-13,15,17-19H,2-3,8-11,14,16H2,1H3,(H2,32,34,35,36)/t18-/m1/s1 | Definition date: | 2019-05-22 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one |
|
![KHT KHT](https://data.pdbj.org/pdbjplus/data/cc/svg/KHT.svg) | KHT | Name: | ~{N}-(cyclopropen-1-ylmethyl)-2-[[4-[[4-[3,3,3-tris(fluoranyl)propanoyl]piperazin-1-yl]methyl]pyridin-2-yl]amino]-1~{H}-benzimidazole-5-carboxamide | Formula: | C25 H26 F3 N7 O2 | SMILES: | FC(F)(F)CC(=O)N1CCN(CC1)Cc2ccnc(Nc3[nH]c4ccc(cc4n3)C(=O)NCC5=CC5)c2 | InChi: | InChI=1S/C25H26F3N7O2/c26-25(27,28)13-22(36)35-9-7-34(8-10-35)15-17-5-6-29-21(11-17)33-24-31-19-4-3-18(12-20(19)32-24)23(37)30-14-16-1-2-16/h1,3-6,11-12H,2,7-10,13-15H2,(H,30,37)(H2,29,31,32,33) | Definition date: | 2019-05-22 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ~{N}-(cyclopropen-1-ylmethyl)-2-[[4-[[4-[3,3,3-tris(fluoranyl)propanoyl]piperazin-1-yl]methyl]pyridin-2-yl]amino]-1~{H}-benzimidazole-5-carboxamide |
|
![Q6S Q6S](https://data.pdbj.org/pdbjplus/data/cc/svg/Q6S.svg) | Q6S | Name: | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide | Formula: | C28 H29 F N4 O3 | SMILES: | N(Cc1cc(cc(c1)OC)OC)C(=O)c3cc(CN2C(/N(C)C=C2)=N)cc(c3)c4ccc(cc4C)F | InChi: | InChI=1S/C28H29FN4O3/c1-18-9-23(29)5-6-26(18)21-10-20(17-33-8-7-32(2)28(33)30)11-22(14-21)27(34)31-16-19-12-24(35-3)15-25(13-19)36-4/h5-15,30H,16-17H2,1-4H3,(H,31,34)/b30-28+ | Definition date: | 2019-09-26 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide |
|
![QJ1 QJ1](https://data.pdbj.org/pdbjplus/data/cc/svg/QJ1.svg) | QJ1 | Name: | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | Formula: | C11 H15 N O2 S2 | SMILES: | c1(sccc1)C2CCN(C(OC)=O)CCS2 | InChi: | InChI=1S/C11H15NO2S2/c1-14-11(13)12-5-4-10(16-8-6-12)9-3-2-7-15-9/h2-3,7,10H,4-6,8H2,1H3/t10-/m0/s1 | Definition date: | 2019-11-04 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
![QJA QJA](https://data.pdbj.org/pdbjplus/data/cc/svg/QJA.svg) | QJA | Name: | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one | Formula: | C11 H13 N O S2 | SMILES: | CC(N1C=CSC(CC1)c2sccc2)=O | InChi: | InChI=1S/C11H13NOS2/c1-9(13)12-5-4-11(15-8-6-12)10-3-2-7-14-10/h2-3,6-8,11H,4-5H2,1H3/t11-/m0/s1 | Definition date: | 2019-11-04 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one |
|